|
FAM114A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.16809999997736E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.722500E-03 |
| Stage1-vs-Stage3 |
7.904400E-02 |
| Stage1-vs-Stage4 |
3.560400E-04 |
| Stage2-vs-Stage3 |
9.952600E-04 |
| Stage2-vs-Stage4 |
2.16610000003392E-06 |
| Stage3-vs-Stage4 |
3.601900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.19010004470977E-09 |
| Normal-vs-Asian |
1.83475457049553E-12 |
| Caucasian-vs-AfricanAmerican |
8.168000E-01 |
| Caucasian-vs-Asian |
9.577600E-01 |
| AfricanAmerican-vs-Asian |
8.546400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.520800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63191682389652E-12 |
| Normal-vs-Age(81-100Yrs) |
2.587400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.694800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.739400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.976600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.549600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.941800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.741400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.412390E-02 |
| Classical-VS-Follicular |
1.098010E-03 |
| Classical-VS-Other |
2.013400E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
3.39879999999848E-06 |
| Tall-VS-Other |
9.841600E-01 |
| Tall-VS-Normal |
1.63102864547682E-12 |
| Follicular-VS-Other |
4.373700E-02 |
| Follicular-VS-Normal |
3.30979999962899E-07 |
| Other-VS-Normal |
1.57040000003938E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.395500E-03 |
|
|
